For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 7

Based on the information you provided, we found the following studies.

  • A Phase I Trial of a combination of chemotherapies ("NECTAR": Nelarabine, Etoposide and Cyclophosphamide) in pediatric patients with T-cell lymphoblastic Leukemia or Lymphoma and bone marrow relapse. To determine maximum tolerated doses & dose-limiting toxicities of nelarabine, etoposide and cyclophosphamide when given to children with precursor T-cell lymphoblastic leukemia (bone marrow relapse) or lymphoblastic lymphoma. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Leukemia Lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • 0 years to 21 years
  • A Phase 4 Safety and Efficacy Study of Bosutinib (Bosulif?) In Patients with Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated with One or More Tyrosine Kinase Inhibitors The purpose of this research study is to collect information on the safety and effectiveness of bosutinib when used to treat patients who have failed treatment with one or more prior TKI treatments for CML. This study is researching all of the following topics: Leukemia This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase 1 Dose Escalation w/Two Disease Specific Expansions, Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of APTO-253 in Patients with Relapsed or Refractory Hematologic Malignancies Study Purpose: test the safety of APTO-253; find the maximum dose of APTO-253 which can be tolerated when given two times a week; find out what effects, good and/or bad, this treatment has on you and your cancer and how APTO-253 may work in the body and your body's ability to get rid of APTO-253. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Hodgkin's lymphoma Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP-CML) This study is designed to obtain information on the safety and the effectiveness of an experimental drug called bosutinib as the first treatment of CML (known as first line therapy).Bosutinib is being compared to treatment with another drug called imatinib. This study is researching all of the following topics: Leukemia This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies Investigational drug carfilzomib will be added to a standard chemotherapy conditioning regimen for donor blood stem cell transplant to test if this new conditioning regimen can lead to safe and more effective stem cell transplant treatment approach for patients with quickly worsening blood cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Amyloidosis CLL ( Chronic lymphocytic leukemia) Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Myelofibrosis Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • Less than 66 years old
    • More than 18 years old
  • Prospective Multi-Center Cohort for the Evaluation of Biomarker Predicting Risk of Complications and Mortality Following Allogenic HCT (CTN 1202) We want to learn more about what makes related and unrelated (allogeneic) bone marrow, blood stem cell and umbilical cord blood transplants work well. This study is researching all of the following topics: Leukemia This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Phase 1/ 2 Study of BMN 673, an Oral Poly(ADP-ribose) Polymerase Inhibitor, Plus Temozolomide in Children with Refractory or Recurrent Malignancies Study goals: find highest safe dose of temozolomide that can be given with experimental drug BMN 673 without causing severe side effects; learn side effects BMN 673 can cause; learn side effects BMN 673/temozolomide combination can cause; learn how your body handles BMN 673/temozolomide combination This study is researching all of the following topics: Brain cancer Leukemia Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 1 years old
    • Less than 21 years old